Baseline prostate-specific antigen levels in midlife predict lethal prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • PSA levels in midlife strongly predict future lethal PCa in a US cohort subject to opportunistic screening. Risk-stratified screening on the basis of midlife PSA should be considered in men age 45 to 59 years.

publication date

  • August 10, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5019757

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.66.7527

PubMed ID

  • 27298404

Additional Document Info

start page

  • 2705

end page

  • 11

volume

  • 34

number

  • 23